Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theralase Technologies Inc. V.TLT.W


Primary Symbol: V.TLT Alternate Symbol(s):  TLTFF

Theralase Technologies Inc is a clinical stage pharmaceutical company. It is dedicated to the research and development of light activated Photo Dynamic Compounds, their associated drug formulations and technology platforms intended to safely and effectively; treat various cancers, bacteria and viruses. The Cool Laser Technology division designs, develops, manufactures and markets proprietary super-pulsed laser technology indicated and cleared by Health Canada and the FDA for the healing of chronic knee pain and when used off-label for healing numerous nerve, muscle and joint conditions. The ACT division conducts preclinical and clinical research and development for PDCs, primarily in the treatment of cancer, with assistance from the CLT division to develop medical lasers to activate them.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

Level ll Quote

THERALASE TECHNOLOGIES INC (CA: TLT)            Real-time   Last:...read more

How much cash does TLT have currently?

Please can someone answer? Anyone except CAinPLAP, thanks.  rate and reply

RE:RE:RE:RE:Potential Rise

Well stated.  As well I think we can really count 14 or at least 13 invalid patients from 1st set of 29.  As 12 were severely undertreated, but afterwards 1 patient who died of HF was...read more

RE:RE:RE:Potential Rise

Hi consultant99 - with all of the BCG-unresponsive NMIBC treatments we have been talking about on this board the initial CR rate declines over time. But there is more going on with our trial that...read more

RE:RE:RE:$0.39 0.005 ( 1.299% ) V:93.95K

CainP:That was sarcasm.  rate and reply

RE:RE:RE:RE:Time to Take some off the Table here? We could see the lows!

Taste of his own medicine he gets, I'm gonna tell his mom that he's at it again. Teenager, eventually they'll grow up, lol. : )  rate and reply

RE:RE:RE:Potential Rise

That's the million dollar question. What was the result of the post-PR analysis. How many have made it into the CR bucket within FDA guidelines  rate and reply

RE:RE:RE:Potential Rise

Good questions consultant - hopefully some enlightenment on the 17th.  rate and reply

RE:RE:Potential Rise

Interesting point raised about more than 2 treatments.  I have wondered if any patients so far that were NR after their first treatment achieved PR or CR after a second treatment. If not is this...read more

RE:RE:RE:Potential Rise

Priority review would have been 6 months instead of 9 months, obliging the FDA to give a response now in February Vs in May?      rate and reply

RE:RE:Potential Rise

It might not be for nothing that the FDA is going for standard review time for IBRX rather than priority review?  Although they got BTD which normally means priority review.  Perhaps they...read more

RE:RE:RE:Time to Take some off the Table here? We could see the lows!

Thanks consultant99 for your thoughts, I see approx 200,000 shares for sale between $0.395 to $0.43, this could add to some selling pressure if others join in, would be best if buyers showed up and...read more

RE:RE:Potential Rise

Anything is possible, but the good thing is that right after BTD, the FDA will give them guidance on possible AA and timeline may be established at that time.  Definitely interesting times ahead....read more

RE:Potential Rise

I did own SESN for a while and then sold. May have a few hundred still left.  In TLTs case, the anticipation will be AA after BTD, so hoping any spike will sustain itself. Curious to see what...read more

RE:Potential Rise

EnriqueSuave ... You think that adding up to 9 new sites would be to validate a cohort of patients receiving let's say 4 doses, instead of just the actual 2 ones?  If so, that would be...read more

RE:Potential Rise

To be specific that preliminary data that SESN bio had presented was at the annual  AUA meeting in May, the same one where our data will be presented on a moderated poster session.  The...read more

RE:RE:Time to Take some off the Table here? We could see the lows!

Go for it sunshine - nobody ever went broke taking a profit. That said today filled the price gap to 0.40 and the next  gap is between 0.43 and 0.45;:rising prices for both shares and warrants...read more

RE:RE:RE:Time to Take some off the Table here? We could see the lows!

Your the shameless one! Your the guy posting on a stock you don't even own? As well it has been non-stop from you for years! All anyone has to do is check the history! Why do you even bother? You...read more

RE:RE:Time to Take some off the Table here? We could see the lows!

For a good laugh, check out what this clown thinks is an invetable stock.. - AMS He's got his panties in a bunch because I have posted on the AMS board what a sham he is trying to pump. This guy...read more

Potential Rise

I remember about 4 years ago when SESN bio went from 0.60 to over $3 ( from February to May a gradual increase) in anticipation of preliminary 90 days data readout on about 55 patients.  The...read more